MedTrace Logo

Lymphedema Treatment in Head and Neck Cancer Patients

NCT04276454 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-08-13

No results posted yet for this study

Summary

The purpose of this research is to evaluate the result of treatment for neck lymphedema on throat pressure in patients who have received radiation therapy for head and neck cancer.

Conditions

Interventions

DEVICE

Flexitouch Plus system

A single treatment for external lymphedema using the FDA-approved Flexitouch Plus device.

Sponsors & Collaborators

  • Tactile Medical

    collaborator INDUSTRY

  • Endeavor Health

    lead OTHER

Principal Investigators

  • Mihir Bhayani, MD · Endeavor Health

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-23
Primary Completion
2020-04-23
Completion
2020-04-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04276454 on ClinicalTrials.gov